Avantor VWR Now Offers CardioChek Plus and A1CNow+

WHITESTOWN, Ind., Oct. 4, 2023—PTS Diagnostics, a leading provider of rapid lipid, blood glucose and A1C testing devices has entered into an agreement with Avantor, a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies, and applied materials industries. This partnership will deliver upon the growing customer need for fast, accurate, and portable blood testing devices.

Biopharma and life science companies who need to regularly test and re-test lipid, glucose and A1C can purchase CardioChek Plus and A1CNow+ test systems from VWR, Avantor’s channel brand. These solutions remove the burden of scheduling and rescheduling appointments for blood draws, and often provide a more comfortable experience for patients by requiring only a fingerstick blood sample. The devices also remove some of the hassles of storage and portability of testing equipment by being small, lightweight, and battery-powered, and by allowing room temperature storage of testing materials and control solutions.

“Through our partnership with Avantor, more clinical professionals will benefit from the efficiencies that CardioChek Plus and A1CNow+ test systems have been bringing to the healthcare industry for years. Our accurate, fast, and easy-to-use blood testing systems, combined with Avantor’s market reach, will allow both companies to fulfill their shared mission of meeting the changing needs of our customers,” said Steve Riendeau, Chief Commercial Officer of PTS Diagnostics.

The partnership with Avantor will expand the availability of PTS Diagnostics flagship products to Avantor’s customers in the point-of-care testing space and will position both companies to offer more flexible solutions for a changing life sciences marketplace.

About PTS Diagnostics
PTS Diagnostics provides innovative, superior quality, point-of-care solutions.  Healthcare professionals have used our CardioChek® products to assess cardiovascular disease risks for millions of patients worldwide through lipid panel screening. Our A1CNow® systems, which provide fast and reliable HbA1c testing, have helped physicians deliver more effective treatments to patients with diabetes. For more information, visit ptsdiagnostics.com.

About Avantor
Avantor®, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the life sciences and technology industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. Our global footprint enables us to serve more than 300,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world. For more information, visit avantorsciences.com and find us on LinkedIn, Twitter and Facebook.


PTS Diagnostics Media Contact

Laurie Gutzwiller
Vice-President Global Marketing